Legalization Was the Easy Part. Now Comes Governing

Americans went to the polls Tuesday worried about the price of groceries and gasoline, health care, tariffs, corruption and a war with Iran. Cannabis legalization didn't exactly crack the top five.

Yet something interesting happened along the way.

In Massachusetts, nearly 76% of voters rejected an attempt to dismantle the state's recreational marijuana marketplace. In deeply conservative Idaho, two-thirds rejected a constitutional amendment that would have prevented citizens from legalizing cannabis through ballot initiatives.

Two very different states, two distinct questions, but a common message: Americans aren't particularly interested in turning back the clock.

That doesn't mean they're satisfied with what legalization has produced.

Across the country, cannabis remains a contradictory collection of expensive regulations, struggling entrepreneurs, complicated taxes, unmet medical promises and consumers who adapt considerably faster than lawmakers.

Which raises a question worth asking as Democrats prepare to control Congress and Donald Trump remains in the White House: What if the path forward for cannabis has less to do with marijuana politics and more to do with the issues voters actually care about?

Affordability. Health care. Economic opportunity. Government accountability.

Imagine that.

Five States, Five Experiments

Consider Wisconsin, where the Milwaukee Brewers just won their first World Series and voters elected Democrat David Crowley governor, handing his party control of both legislative chambers.

Crowley supports legalization. But the opportunity is considerably larger than adding Wisconsin to the growing collection of states with recreational dispensaries.

Wisconsin can learn from its neighbors, each conducting a different experiment in cannabis governance.

Illinois established one of America's most tightly regulated marketplaces, promising social equity alongside economic opportunity. The original ambition was considerable; execution considerably messier. Limited licenses, high taxes, expensive compliance and uneven access to capital have made survival challenging, particularly for the entrepreneurs legalization was supposed to empower.

The question today isn't whether social equity mattered. It's whether the state created conditions for the businesses it championed to succeed.

Meanwhile, Illinois is helping build a national THC beverage industry, with companies including Green Thumb Industries and Plift pursuing consumers beyond traditional dispensaries.

As Axios Chicago reported Thursday, new restrictions taking effect November 12 threaten sales of many hemp-derived THC beverages in liquor stores.

Grown In's observation in that story: Consumers are once again ahead of lawmakers, regulators and the industry itself.

Missouri offers another model. A Republican-leaning state with a comparatively restrained licensing framework, Missouri recently commissioned research estimating that 93% of cannabis purchases occur through regulated dispensaries.

That's a remarkable claim, although the survey methodology and assumptions deserve scrutiny.

Missouri's approach includes social equity-oriented microbusiness licenses but places greater emphasis on market stability and measured expansion. State regulators currently see no need for additional licenses.

Is that responsible regulation or government protecting incumbent businesses? Perhaps elements of both.

Michigan took another route, embracing comparatively open competition rooted in a cannabis culture that stretches from Ann Arbor's pioneering Hash Bash to medical caregivers and home cultivation.

Consumers enjoy substantially lower prices. Businesses face brutal competition and consolidation. Michigan's new 24% wholesale tax adds another burden to an already difficult operating environment.

Low prices aren't necessarily evidence of a broken marketplace. Neither is business failure. But an industry where consumers prosper while producers cannot survive indefinitely presents legitimate governing questions.

Kentucky, meanwhile, is building a medical cannabis program alongside an established hemp agricultural economy. Its experience raises questions about rural development, patient access, research and what happens when traditional farming meets modern pharmaceutical expectations.

Five states, five approaches. No definitive answer.

And Wisconsin has an opportunity to build on all of them.

Follow the Voters, Not the Lobbyists

The most revealing election statistic isn't about cannabis.

According to Gallup, the economy and health care were extremely important to half of registered voters, with the Iran conflict close behind.

That should inform how cannabis reform is discussed in 2027.

Affordability means examining whether excessive taxes and regulatory barriers push consumers toward illicit sellers.

Health care means prioritizing patients, clinical research, product safety and access rather than treating medical cannabis as another revenue stream.

Economic opportunity means ensuring licensing systems encourage competition without making legitimate businesses economically impossible.

Government accountability means asking whether regulatory restrictions protect consumers or simply protect companies already holding licenses.

These aren't exclusively Democratic or Republican concerns. They're familiar questions about how markets function, who benefits and whether government delivers what it promises.

And the hemp beverage controversy illustrates the dilemma perfectly.

Dispensaries invested heavily to comply with government regulations. Beverage entrepreneurs developed alternative distribution channels. Consumers embraced products that didn't fit neatly into either system.

Who should government protect?

The answer shouldn't automatically be whichever industry has the strongest lobbyist.

The Trump Wildcard

Which brings us back to Washington.

Trump and congressional Democrats will disagree about plenty in 2027. Health care spending, tariffs, immigration and investigations will consume enormous political oxygen. Presidential positioning for 2028, including from Illinois Gov. JB Pritzker, won't help.

But could cannabis become an unlikely example of divided government actually governing?

Trump's administration has already embraced accelerated research into psychedelic therapies, particularly for veterans and patients with serious mental health conditions.

Medical cannabis research, federal tax reform, banking access and consistent hemp regulations offer potential opportunities for cooperation without requiring agreement on comprehensive recreational legalization.

None will be simple. Federal rescheduling remains unresolved, and medical innovation deserves rigorous science rather than another round of exaggerated promises.

Still, imagine a Republican president and Democratic Congress finding agreement around patients, small businesses, agriculture and consumer protection.

Not because anyone abandoned their principles, but because practical solutions served more people than political posturing.

That's not necessarily compromise in the conventional sense. It's governing.

The cannabis movement spent decades asking government to get out of the way.

Now comes the harder assignment: demonstrating where government should intervene, where markets should operate freely, and how to measure whether either approach works.

Wisconsin has an opportunity to help answer those questions. Washington might even be listening.

Legalization was the easy part.

The real experiment is just beginning.